Moderna Loses AstraZeneca's Support in IL-2 Program, must Defend Arbutus Suit 0 03.11.2022 03:00 Feedity.com Moderna is dropping an IL-2 program in autoimmune disorders after AstraZeneca returned the rights, the mRNA leader announced Thursday in its third quarter filing. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
